AHG Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 5.31
- P/S (TTM)
- 70.42
- EV/EBITDA
- -0.39
Profitability & growth
- ROE (TTM)
- -68.3%
- Operating margin
- -20.5%
- Revenue growth YoY
- 0.9%
- Dividend yield
- —
- Beta
- -1.02
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Akso Health Group ADR
Company profileAkso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NASDAQ
- Country
- China
- Currency
- USD
Company profile
- HQ
- QIANTONGYUAN BUILDING, QINGDAO, CHINA
- Fiscal year end
- March
- Latest quarter
- Jun 30, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer